IntegReview IRB

IntegReview IRB

Share

IntegReview is a fully accredited IRB responsible for providing protection to human research subjects in the pharmaceutical industry since 1999.

10/29/2020

's
https://lnkd.in/g2YHeuk

FDA Approves First Treatment for COVID-19 10/22/2020

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19?utm_medium=email&utm_source=govdelivery

FDA Approves First Treatment for COVID-19 FDA approved Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization

10/16/2020

A year ago, the cystic fibrosis community celebrated the approval of Trikafta, a highly effective CFTR modulator for individuals who have at least one copy of the F508del mutation. Join us on Facebook Live Thursday, October 22 at 1 p.m. ET for plenary two of NACFC led by Jennifer Taylor-Cousar, MD, MSc, to learn about the amazing progress in our understanding of the benefits of highly effective CFTR modulators.

Want your school to be the top-listed School/college in Austin?
Click here to claim your Sponsored Listing.

Telephone

Address


3815 S Capital Of Texas Highway, Ste 320
Austin, TX
78704

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm